Zocco, Maria Assunta
 Distribuzione geografica
Continente #
EU - Europa 6.006
NA - Nord America 4.486
AS - Asia 2.250
SA - Sud America 233
AF - Africa 74
OC - Oceania 54
Continente sconosciuto - Info sul continente non disponibili 21
Totale 13.124
Nazione #
US - Stati Uniti d'America 4.393
DE - Germania 2.444
SE - Svezia 1.050
SG - Singapore 830
IT - Italia 779
CN - Cina 727
UA - Ucraina 375
FR - Francia 266
GB - Regno Unito 259
IE - Irlanda 248
BR - Brasile 200
ID - Indonesia 159
FI - Finlandia 151
IN - India 151
RU - Federazione Russa 122
TR - Turchia 95
CA - Canada 69
BE - Belgio 55
AU - Australia 50
PL - Polonia 47
NL - Olanda 42
IR - Iran 35
HK - Hong Kong 32
AT - Austria 29
CH - Svizzera 26
SA - Arabia Saudita 22
VN - Vietnam 20
CZ - Repubblica Ceca 19
JP - Giappone 19
PH - Filippine 19
CI - Costa d'Avorio 17
AE - Emirati Arabi Uniti 16
EU - Europa 16
IL - Israele 16
RO - Romania 16
LT - Lituania 15
PK - Pakistan 14
TW - Taiwan 12
BD - Bangladesh 11
EG - Egitto 10
MY - Malesia 10
PT - Portogallo 10
TN - Tunisia 10
MX - Messico 9
CL - Cile 8
GR - Grecia 8
KR - Corea 8
ZA - Sudafrica 8
AR - Argentina 7
ES - Italia 7
KG - Kirghizistan 7
MA - Marocco 7
UZ - Uzbekistan 7
CO - Colombia 6
PA - Panama 6
SD - Sudan 6
EC - Ecuador 5
EE - Estonia 5
IQ - Iraq 5
JO - Giordania 5
NO - Norvegia 5
TH - Thailandia 5
AL - Albania 4
AZ - Azerbaigian 4
KE - Kenya 4
ML - Mali 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
A1 - Anonimo 3
DO - Repubblica Dominicana 3
HR - Croazia 3
MK - Macedonia 3
NG - Nigeria 3
RS - Serbia 3
BG - Bulgaria 2
CM - Camerun 2
HN - Honduras 2
HU - Ungheria 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LV - Lettonia 2
MD - Moldavia 2
MG - Madagascar 2
MO - Macao, regione amministrativa speciale della Cina 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
GL - Groenlandia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
Totale 13.115
Città #
Chandler 910
Singapore 514
Ashburn 327
Dublin 245
New York 193
Jacksonville 190
San Mateo 190
Rome 179
Ann Arbor 167
Jakarta 157
Nürnberg 157
Nanjing 131
Cattolica 120
Marseille 113
Milan 110
Wilmington 107
The Dalles 106
Chicago 104
Munich 94
Boston 89
Beijing 88
Woodbridge 79
Izmir 78
Moscow 74
Princeton 73
Helsinki 72
Dearborn 68
Bremen 64
Seattle 62
Boardman 61
Los Angeles 58
Frankfurt am Main 50
Brussels 49
Nanchang 45
Düsseldorf 41
Houston 40
Redwood City 39
Hangzhou 36
Fairfield 35
Zhengzhou 34
Tianjin 31
North Bergen 30
Hebei 28
Lawrence 28
Kraków 27
Nuremberg 27
Lancaster 26
London 26
Hong Kong 25
Norwalk 25
Pune 24
University Park 24
Augusta 23
Guangzhou 22
Leawood 22
Toronto 22
Hyderabad 21
Mountain View 21
Shenyang 20
Changsha 19
Fremont 19
Portsmouth 19
Abidjan 17
Jiaxing 17
Ottawa 16
Kunming 15
Shanghai 15
São Paulo 15
Vienna 15
Zurich 15
Warsaw 14
Santa Clara 13
Council Bluffs 12
Dammam 11
Falkenstein 11
Lauterbourg 11
Jinan 10
Kish 10
Lappeenranta 10
Québec 10
Simi Valley 10
Taipei 10
Amsterdam 9
Andover 9
Detroit 9
Sydney 9
Campagna 8
Newark 8
Ningbo 8
Oggiono 8
Paris 8
San Diego 8
San Jose 8
Al Qatif 7
Bishkek 7
Boydton 7
Brno 7
Edinburgh 7
Lahore 7
Las Vegas 7
Totale 6.276
Nome #
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 449
Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment 287
From small nodule to overt HCC: a multistep process of carcinogenesis as seen during surveillance 285
13C-methionine breath tests for mitochondrial liver function assessment. 213
13C-breath tests in the study of microsomal liver function 196
The role of small intestinal bacterial overgrowth in Parkinson's disease 191
Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity. 183
-High prevalence of celiac disease in patients with lactose intolerance 182
-Hepatic steatosis and vascular disease 176
-Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure 171
-Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity 168
134C-breath tests in the study of mitochondrial liver function 161
A) Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. 159
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease 157
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 148
13C-breath tests in the study of microsomial liver function 143
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications 142
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development 140
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 140
-Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection. 138
13C-methionine breath tests for mitochondrial liver function assessment 138
-No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute on chronic liver failure 138
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 137
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication 137
-How does human stem cell therapy influence gene expression after liver injury? Microarray evaluation on a rat model 134
Something more to say about calcium homeostasis: the role of vitamin K2 in vascular calcification and osteoporosis 133
Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats. 129
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 129
-Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats 128
Treatment of H. pylori infection: a review. 126
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. 125
CD133+ stem cell mobilization after partial hepatectomy depends on resection extent and underlying disease 125
. High prevalence of Cag-A positive H. pylori strains in ischemic stroke: a primary care multicenter study. 123
Delta13CO2 excretion and expression of dyspeptic symptoms in patients evaluated for Helicobacter pylori infection by [13C] urea breath test 121
Beta-lactamase inhibitor enhances Helicobacter pylori eradication rate. 119
-Bacillus clausii effect on gene expression pattern in small bowel mucosa using DNA microarray analysis 119
13C-breath tests in the study of mitochondrial liver function 119
-The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure 115
Transarterial chemoembolization with degradable starch microspheres (DSM-TACE): an alternative option for advanced HCC patients? Preliminary results 115
Diagnosis of bowel diseases: the role of imaging and ultrasonography 114
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 111
Levofloxacin based regimens for the eradication of Helicobacter pylori 110
-Improvement of mitochondrial function evaluated by ketoisocaproic acid breath test in patients with HCV infection undergoing albumin dialysis 110
Prevention and treatment of hepatic encephalopathy: focusing on gut microbiota 110
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 109
Something more to say about calcium homeostasis: the role of vitamin K2 in vascular calcification and osteoporosis 107
Portal vein tumor thrombosis revascularization during sorafenib treatment for hepatocellular carcinoma 106
Transdifferentiation of stem cells in pancreatic cells: state of the art 105
Liver transplantation in patients with alcoholic liver disease: A retrospective study 105
-Can 13C urea breath test predict resistance to therapy in Helicobacter pylori infection? 103
. Quick test: a new test for the diagnosis of duodenal hypolactasia. 102
Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth 102
Bacteroides thetaiotaomicron in the gut: molecular aspects of their interaction. 101
Regression of lactose malabsorption in coeliac patients after receiving a gluten-free diet. 100
-From stem cell to solid organ. Bone marrow, peripheral blood or umbilical cord blood as favorable source? 100
Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis 97
High Prevalence and Gender-Related Differences of Gastrointestinal Manifestations in a Cohort of DM1 Patients: A Perspective, Cross-Sectional Study 97
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 96
How does human stem cell therapy influence gene expression after liver injury? Microarray evaluation on a rat model 91
Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication 91
Something more to say about calcium homeostasis: the role of vitamin K2 in vascular calcification and osteoporosis. 91
Different Antibiotic No Culture Eradicating (DANCE) strategy: An easy way to manage H. pylori eradication 89
Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis. 88
Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1) 88
Saccharomyces boulardii and Antibiotic-Associated Diarrhea: Effectiveness of Prophylactic Use 87
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 87
Residual respiratory impairment after COVID-19 pneumonia 86
Anticoagulants in cirrhotic patients: controversies and certainties in PVT management 84
Is there a role for anticoagulants in portal vein thrombosis management in cirrhotic patients? 84
Correlation Between QElaXto Techniques and Supersonic Imagine for Liver Stiffness Quantification in Chronic Liver Disease 84
Liver Stiffness in Pediatric Patients with Fatty Liver Disease: Diagnostic Accuracy and Reproducibility of Shear-Wave Elastography 83
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 81
Review article: breath testing for human liver function assessment. 80
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 79
Functional and metabolic disorders in celiac disease: new implications for nutritional treatment 78
Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatment 78
A) Quantitative evaluation of liver function by the methionine and aminopyrine breath tests in the early stages of liver transplantation 77
What we should know about portal vein thrombosis in cirrhotic patients: A changing perspective 77
Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms 77
Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma 76
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules 76
Madelung's disease and acute alcoholic hepatitis: case report and review of literature 70
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 70
Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience 68
A novel ultrasound-based vascular calcification score (CALCS) to detect subclinical atherosclerosis 68
Minimal Hepatic Encephalopathy is Associated with Increased Cerebral Vascular Resistance. A Transcranial Doppler Ultrasound Study 68
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in children with household exposure to adults with COVID-19: Preliminary findings 67
Probiotics and small bowel mucosa: Molecular aspects of their interactions 66
Clinical use of albumin in hepatology. 65
Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients undergoing anti-TNFα therapy 64
Malnutrition in COVID-19 survivors: prevalence and risk factors 63
Usefulness of contrast-enhanced ultrasound (CEUS) in Inflammatory Bowel Disease (IBD) 61
ADAMTS-13/von Willebrand factor ratio: A prognostic biomarker for portal vein thrombosis in compensated cirrhosis. A prospective observational study 60
-Helicobacter pylori and extragastric diseases--other Helicobacters 59
Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C 59
Idiopathic chronic constipation: pathophysiology, diagnosis and treatment 58
Portal vein thrombosis and liver transplantation: Implications for waiting list period, surgical approach, early and late follow-up. 58
The role of elastography in non-Alcoholic fatty liver disease 57
Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate 55
COVID-19 atypical Parsonage-Turner syndrome: a case report 53
Totale 11.325
Categoria #
all - tutte 60.545
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.545


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020241 0 0 0 0 0 0 0 0 0 0 154 87
2020/20211.136 89 86 35 82 117 61 101 31 128 182 196 28
2021/20221.176 86 97 36 95 94 35 25 190 34 64 185 235
2022/20233.146 349 349 254 523 270 398 187 215 309 122 121 49
2023/20241.533 79 356 60 44 66 262 89 48 30 118 168 213
2024/20252.351 68 80 276 137 303 109 168 205 509 389 107 0
Totale 13.289